These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16183526)

  • 1. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology of somatostatin receptors.
    Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
    J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease.
    Höcker M; Wiedenmann B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S139-42. PubMed ID: 10604118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
    Bodelier AG; Haak HR
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular biology of somatostatin receptors.
    Csaba Z; Dournaud P
    Neuropeptides; 2001 Feb; 35(1):1-23. PubMed ID: 11346306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of somatostatin.
    Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
    Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptors and regulation of cell proliferation.
    Bousquet C; Guillermet J; Vernejoul F; Lahlou H; Buscail L; Susini C
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S2-7. PubMed ID: 15077905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular signaling of somatostatin receptors.
    Lahlou H; Guillermet J; Hortala M; Vernejoul F; Pyronnet S; Bousquet C; Susini C
    Ann N Y Acad Sci; 2004 Apr; 1014():121-31. PubMed ID: 15153426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
    Spary EJ; Maqbool A; Batten TF
    J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy.
    Baudin E
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):228-39. PubMed ID: 17315031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning.
    Durán-Prado M; Malagón MM; Gracia-Navarro F; Castaño JP
    Mol Cell Endocrinol; 2008 May; 286(1-2):63-8. PubMed ID: 18242821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future aspects of somatostatin-receptor-mediated therapy.
    Oberg K
    Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
    Gibril F; Jensen RT
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours.
    Zamora V; Cabanne A; Salanova R; Bestani C; Domenichini E; Marmissolle F; Giacomi N; O'Connor J; Méndez G; Roca E;
    Dig Liver Dis; 2010 Mar; 42(3):220-5. PubMed ID: 19819769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptors.
    Benali N; Ferjoux G; Puente E; Buscail L; Susini C
    Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.
    Dasgupta P
    Pharmacol Ther; 2004 Apr; 102(1):61-85. PubMed ID: 15056499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
    de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
    Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.